challenges in tnbc
Published 2 years ago • 192 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:02
challenges in identifying predictive markers to icis in triple-negative breast cancer
-
2:21
the challenges of treating early-stage tnbc
-
0:51
challenges in the treatment of mtnbc
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
1:15
clinical implications of progress in tnbc therapies
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
0:42
can anthracyclines be omitted in tnbc?
-
10:40
the biggest challenges in metastatic triple-negative breast cancer
-
0:41
the importance of brca-1 testing in triple negative breast cancer
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
2:05
treatment advances in tnbc
-
0:58
personalizing approaches in early-stage tnbc
-
1:58
targeted therapy in tnbc
-
0:41
recent advances in targeted therapies for tnbc
-
1:51
optimal chemotherapy combinations in tnbc gbrca subtypes
-
2:07
the association between jnk activity and immunotherapeutic efficacy of io in tnbc
-
0:43
management of residual disease in triple negative breast cancer
-
1:00
overcoming challenges in treating patients with triple-negative breast cancer
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer